한글목차

개요

패혈증 치료제 시장은 2023년부터 2028년에 걸쳐 14억 2,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR) 6.98%로 성장할 것으로 예측됩니다.

패혈증 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다.패혈증 발생률 증가, 세계의 고령자 인구 증가, 헬스케어 인프라 개선 등이 시장 성장을 가속하고 있습니다.

본 조사에서는 향후 몇 년간 패혈증 치료제 시장 성장을 가속하는 주요 이유 중 하나로서 패혈증 치료에서의 정밀의료 이용에 대한 주목이 높아지고 있는 것을 들고 있습니다. 또한 패혈증 치료를 위한 새로운 치료제 개척, 패혈증 진단과 관리의 발전이 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 패혈증 치료제 시장(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 병원 : 시장 규모와 예측(2023-2028년)
• 클리닉 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제7장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 항균 요법 : 시장 규모와 예측(2023-2028년)
• 보조 요법 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아태평양 : 시장 규모와 예측(2023-2028년)
• 남미 : 시장 규모와 예측(2023-2028년)
• 중동 및 아프리카 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Adrenomed AG
• Astellas Pharma Inc.
• AstraZeneca Plc
• bioMerieux SA
• CytoSorbents Corp.
• F. Hoffmann La Roche Ltd.
• Hikma Pharmaceuticals Plc
• Inotrem S.A.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Spectral Medical Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

제13장 부록

영문목차

Abstract

The sepsis therapeutics market is forecasted to grow by USD 1.42 bn during 2023-2028, accelerating at a CAGR of 6.98% during the forecast period. The report on the sepsis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of sepsis, rising geriatric population globally, and improvements in healthcare infrastructure.

Technavio's sepsis therapeutics market is segmented as below:

By Application

• Hospitals
• Clinics
• Others

By Type

• Antimicrobial therapy
• Adjunctive therapy

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the increasing focus on use of precision medicine in sepsis treatment as one of the prime reasons driving the sepsis therapeutics market growth during the next few years. Also, new therapeutics development for sepsis treatment and advances in sepsis diagnosis and management will lead to sizable demand in the market.

The report on the sepsis therapeutics market covers the following areas:

• Sepsis therapeutics market sizing
• Sepsis therapeutics market forecast
• Sepsis therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sepsis therapeutics market vendors that include Adrenomed AG, AM Pharma BV, Astellas Pharma Inc., AstraZeneca Plc, bioMerieux SA, CytoSorbents Corp., F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc, Inotrem S.A., Novartis AG, Pfizer Inc., Sanofi SA, Spectral Medical Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the sepsis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global sepsis therapeutics market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global sepsis therapeutics market 2018 - 2022 ($ billion)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 6.4 Clinics - Market size and forecast 2023-2028
• Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
• 6.5 Others - Market size and forecast 2023-2028
• Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Application
• Exhibit 46: Market opportunity by Application ($ billion)
• Exhibit 47: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Antimicrobial therapy - Market size and forecast 2023-2028
• Exhibit 52: Chart on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
• 7.4 Adjunctive therapy - Market size and forecast 2023-2028
• Exhibit 56: Chart on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 60: Market opportunity by Type ($ billion)
• Exhibit 61: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 APAC - Market size and forecast 2023-2028
• Exhibit 75: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on APAC - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on APAC - Year-over-year growth 2023-2028 (%)
• 9.6 South America - Market size and forecast 2023-2028
• Exhibit 79: Chart on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on South America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on South America - Year-over-year growth 2023-2028 (%)
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
• Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• 9.8 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 UK - Market size and forecast 2023-2028
• Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.13 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Adrenomed AG
• Exhibit 115: Adrenomed AG - Overview
• Exhibit 116: Adrenomed AG - Product / Service
• Exhibit 117: Adrenomed AG - Key offerings
• 12.4 Astellas Pharma Inc.
• Exhibit 118: Astellas Pharma Inc. - Overview
• Exhibit 119: Astellas Pharma Inc. - Product / Service
• Exhibit 120: Astellas Pharma Inc. - Key news
• Exhibit 121: Astellas Pharma Inc. - Key offerings
• 12.5 AstraZeneca Plc
• Exhibit 122: AstraZeneca Plc - Overview
• Exhibit 123: AstraZeneca Plc - Product / Service
• Exhibit 124: AstraZeneca Plc - Key news
• Exhibit 125: AstraZeneca Plc - Key offerings
• 12.6 bioMerieux SA
• Exhibit 126: bioMerieux SA - Overview
• Exhibit 127: bioMerieux SA - Product / Service
• Exhibit 128: bioMerieux SA - Key offerings
• 12.7 CytoSorbents Corp.
• Exhibit 129: CytoSorbents Corp. - Overview
• Exhibit 130: CytoSorbents Corp. - Product / Service
• Exhibit 131: CytoSorbents Corp. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 Hikma Pharmaceuticals Plc
• Exhibit 137: Hikma Pharmaceuticals Plc - Overview
• Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
• 12.10 Inotrem S.A.
• Exhibit 141: Inotrem S.A. - Overview
• Exhibit 142: Inotrem S.A. - Product / Service
• Exhibit 143: Inotrem S.A. - Key offerings
• 12.11 Novartis AG
• Exhibit 144: Novartis AG - Overview
• Exhibit 145: Novartis AG - Business segments
• Exhibit 146: Novartis AG - Key offerings
• Exhibit 147: Novartis AG - Segment focus
• 12.12 Pfizer Inc.
• Exhibit 148: Pfizer Inc. - Overview
• Exhibit 149: Pfizer Inc. - Product / Service
• Exhibit 150: Pfizer Inc. - Key news
• Exhibit 151: Pfizer Inc. - Key offerings
• 12.13 Sanofi SA
• Exhibit 152: Sanofi SA - Overview
• Exhibit 153: Sanofi SA - Business segments
• Exhibit 154: Sanofi SA - Key news
• Exhibit 155: Sanofi SA - Key offerings
• Exhibit 156: Sanofi SA - Segment focus
• 12.14 Spectral Medical Inc.
• Exhibit 157: Spectral Medical Inc. - Overview
• Exhibit 158: Spectral Medical Inc. - Product / Service
• Exhibit 159: Spectral Medical Inc. - Key offerings
• 12.15 Takeda Pharmaceutical Co. Ltd.
• Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 169: Viatris Inc. - Overview
• Exhibit 170: Viatris Inc. - Business segments
• Exhibit 171: Viatris Inc. - Key news
• Exhibit 172: Viatris Inc. - Key offerings
• Exhibit 173: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 176: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources
• 13.5 List of abbreviations
• Exhibit 180: List of abbreviations